ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
2.630
+0.040 (1.54%)
Dec 20, 2024, 4:00 PM EST - Market closed
ProQR Therapeutics Market Cap
ProQR Therapeutics has a market cap or net worth of $271.43 million as of December 20, 2024. Its market cap has increased by 57.90% in one year.
Market Cap
271.43M
Enterprise Value
191.12M
1-Year Change
57.90%
Ranking
Category
Stock Price
$2.63
Market Cap Chart
Since September 18, 2014, ProQR Therapeutics's market cap has decreased from $308.80M to $271.43M, a decrease of -12.10%. That is a compound annual growth rate of -1.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 20, 2024 | 221.60M | 32.85% |
Dec 29, 2023 | 166.80M | -39.78% |
Dec 30, 2022 | 277.00M | -53.81% |
Dec 31, 2021 | 599.70M | 164.07% |
Dec 31, 2020 | 227.10M | -46.89% |
Dec 31, 2019 | 427.60M | -15.11% |
Dec 31, 2018 | 503.70M | 568.92% |
Dec 29, 2017 | 75.30M | -34.18% |
Dec 30, 2016 | 114.40M | -43.53% |
Dec 31, 2015 | 202.60M | -55.40% |
Dec 31, 2014 | 454.30M | 47.12% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
COMPASS Pathways | 277.79M |
Chimerix | 277.45M |
Zynex | 277.37M |
Accolade | 277.05M |
aTyr Pharma | 277.01M |
C4 Therapeutics | 273.53M |
AC Immune | 272.09M |
OraSure Technologies | 271.90M |